A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Advancements in next-generation sequencing and other -omics technologies are accelerating the detailed molecular characterization of individual patient tumors, and driving the evolution of precision medicine. Cancer is no longer considered a single disease, but rather, a diverse array of diseases wherein each patient has a unique collection of germline variants and somatic mutations. Molecular profiling of patient-derived samples has led to a data explosion that could help us understand the contributions of environment and germline to risk, therapeutic response, and outcome. To maximize the value of these data, an interdisciplinary approach is paramount. The National Cancer Institute (NCI) has initiated multiple projects to characterize tumor samples using multi-omic approaches. These projects harness the expertise of clinicians, biologists, computer scientists, and software engineers to investigate cancer biology and therapeutic response in multidisciplinary teams. Petabytes of cancer genomic, transcriptomic, epigenomic, proteomic, and imaging data have been generated by these projects. To address the data analysis challenges associated with these large datasets, the NCI has sponsored the development of the Genomic Data Commons (GDC) and three Cloud Resources. The GDC ensures data and metadata quality, ingests and harmonizes genomic data, and securely redistributes the data. During its pilot phase, the Cloud Resources tested multiple cloud-based approaches for enhancing data access, collaboration, computational scalability, resource democratization, and reproducibility. These NCI-led efforts are continuously being refined to better support open data practices and precision oncology, and to serve as building blocks of the NCI Cancer Research Data Commons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Toward a Shared Vision for Cancer Genomic Data
Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1607591 · Cited by 1,680 · cited 5×
“…Center for Data Intensive Science, in collaboration with Ontario Institute for Cancer Research, all under an NCI contract with Leidos Biomedical Research, is a unified genomic data repository that hosts authoritative NCI reference datasets such as TCGA and TARGET (Grossman et al., 2016; NIH, 2016).”
MethodInfluentialSelf-citationProteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Proteogenomic characterization of human colon and rectal cancer
CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., et al. (2014) · Nature · doi:10.1038/nature13438 · Cited by 1,462
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422 · cited 1×
“Through genomic and transcriptomic analyses, researchers are studying the relationships among alterations at the DNA and RNA levels, cancer growth, cancer progression, and pediatric patient survival (Mullighan et al., 2009; Pugh et al., 2013; Eleveld et al., 2015).”
Background
Research works printed but not linked: 17
- Andersen, How Big Data is Changing Astronomy (Again)
- 2008, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 455, 1061, 10.1038/nature07385 · DOI · Paper page
- 2011, Integrated genomic analyses of ovarian carcinoma, Nature, 474, 609, 10.1038/nature10166 · DOI · Paper page
- 2017, Integrated genomic and molecular characterization of cervical cancer, Nature, 543, 378, 10.1038/nature21386 · DOI · Paper page
- 2012, Comprehensive molecular portraits of human breast tumours, Nature, 490, 61, 10.1038/nature11412 · DOI · Paper page
- Eleveld, 2015, Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations, Nat. Genet., 47, 864, 10.1038/ng.3333 · DOI · Paper page
- Hsieh, 2017, Statistical algorithms improve accuracy of gene fusion detection, Nucleic Acids Res., 45, e126, 10.1093/nar/gkx453 · DOI
- Hyman, 2017, Implementing genome-driven oncology, Cell, 168, 584, 10.1016/j.cell.2016.12.015 · DOI · Paper page
- Knoppers, 2014, Framework for responsible sharing of genomic and health-related data, Hugo J., 8, 3, 10.1186/s11568-014-0003-1 · DOI · Paper page
- Mons, 2017, Cloudy, increasingly FAIR; revisiting the FAIR Data guiding principles for the European Open Science Cloud, Inf. Serv. Use, 37, 49, 10.3233/ISU-170824 · DOI · Paper page
- 2017, The NCI Cancer Research Data Commons: An Expandable Infrastructure
- Paulovich, 2010, Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance, Mol. Cell. Proteomics, 9, 242, 10.1074/mcp.M900222-MCP200 · DOI · Paper page
- Pugh, 2013, The genetic landscape of high-risk neuroblastoma, Nat. Genet., 45, 279, 10.1038/ng.2529 · DOI · Paper page
- Salzman, 2017, Cancer genomics cloud pilot user talks: sensitive and specific gene fusion detection in the, NCI seven bridges cloud pilot,
- Tatlow, 2016, A cloud-based workflow to quantify transcript-expression levels in public cancer compendia, Sci. Rep., 6, 39259, 10.1038/srep39259 · DOI · Paper page
- Ulrich, 2016, Time to Light the Firecloud
- Zhang, 2016, Integrated proteogenomic characterization of human high-grade serous ovarian cancer, Cell, 166, 755, 10.1016/j.cell.2016.05.069 · DOI · Paper page
Cited by
AI in Medical Imaging Informatics: Current Challenges and Future Directions
Panayides, A. S., Amini, A., Filipovic, N. D., Sharma, A., Tsaftaris, S. A., Young, A., Foran, D., Do, N., Golemati, S., Kurc, T., et al. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2991043 · Cited by 713
Mounir, M., Lucchetta, M., Silva, T. C., Olsen, C., Bontempi, G., Chen, X., Noushmehr, H., Colaprico, A., & Papaleo, E. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006701 · Cited by 530
From hype to reality: data science enabling personalized medicine
Fröhlich, H., Balling, R., Beerenwinkel, N., Kohlbacher, O., Kumar, S., Lengauer, T., Maathuis, M. H., Moreau, Y., Murphy, S. A., Przytycka, T. M., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1122-7 · Cited by 414
Multimodal data fusion for cancer biomarker discovery with deep learning
Steyaert, S., Pizurica, M., Nagaraj, D., Khandelwal, P., Hernandez-Boussard, T., Gentles, A. J., & Gevaert, O. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00633-5 · Cited by 402
“Large consortia such as The Cancer Genome Atlas (TCGA) and Genomic Data Commons have gathered and standardized large datasets, accumulating petabytes of genomic, expression and proteomics data 37,49,50 .”
BackgroundData Integration Challenges for Machine Learning in Precision Medicine
Martínez-García, M., & Hernández-Lemus, E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.784455 · Cited by 185
Metadata
- Authors
- Hinkson, I. V., Davidsen, T. M., Klemm, J. D., Chandramouliswaran, I., Kerlavage, A. R., & Kibbe, W. A.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2017-09-21
- Volume
- 5
- Pages
- 108-108
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2757281736
- Cited by
- 88
- References
- 5
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Update notices
- corrigendum (2017-12-07)
- Open access
- gold
- Funders
- National Cancer Institute (HHSN261200800001E, HHSN261201400006C, HHSN261201400007C, HHSN261201400008C)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine. https://app.cochat.ai/papers/10.3389/fcell.2017.00083
- The paper
- Hinkson, I. V., Davidsen, T. M., Klemm, J. D., Chandramouliswaran, I., Kerlavage, A. R., & Kibbe, W. A. (2017). A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2017.00083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.